(0.33%) 5 116.76 points
(0.30%) 38 354 points
(0.37%) 15 987 points
(-0.87%) $83.12
(5.77%) $2.03
(0.44%) $2 357.60
(0.47%) $27.67
(3.91%) $958.20
(-0.22%) $0.933
(-0.38%) $10.98
(-0.54%) $0.796
(1.66%) $93.40
4 days till quarter result
(bmo 2024-05-03)
Expected move: +/- 10.42%
Live Chart Being Loaded With Signals
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland...
Stats | |
---|---|
本日の出来高 | 330 887 |
平均出来高 | 336 670 |
時価総額 | 1.31B |
EPS | $0 ( 2024-02-26 ) |
次の収益日 | ( $0 ) 2024-05-03 |
Last Dividend | $0.100 ( 2012-09-26 ) |
Next Dividend | $0 ( N/A ) |
P/E | -62.49 |
ATR14 | $0.901 (0.75%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-06-13 | Davis Stephen L | Sell | 500 | Common Stock |
2023-06-13 | Hasenmaier Joachim A. | Sell | 2 004 | Common Stock |
2023-06-13 | Eyl Steven M. | Buy | 4 056 | Common Stock |
2023-06-13 | Eyl Steven M. | Buy | 33 111 | Common Stock |
2022-02-28 | Eyl Steven M. | Buy | 20 000 | Non-Qualified Stock Option (right to buy) |
INSIDER POWER |
---|
-9.05 |
Last 100 transactions |
Buy: 575 941 | Sell: 596 011 |
ボリューム 相関
Heska Corp 相関
10 最も正の相関 | |
---|---|
ATCX | 0.919 |
BRACU | 0.916 |
SYKE | 0.912 |
SPRB | 0.905 |
XLRN | 0.905 |
GRNQ | 0.902 |
JFIN | 0.893 |
ICON | 0.89 |
RDUS | 0.888 |
AEYE | 0.883 |
10 最も負の相関 | |
---|---|
AHPI | -0.894 |
SBBP | -0.887 |
TUEM | -0.88 |
VIEW | -0.872 |
VERA | -0.867 |
GRPH | -0.858 |
ARDS | -0.856 |
RPTX | -0.845 |
NAKD | -0.83 |
YJ | -0.829 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Heska Corp 相関 - 通貨/商品
Heska Corp 財務諸表
Annual | 2022 |
収益: | $257.31M |
総利益: | $111.17M (43.20 %) |
EPS: | $-1.780 |
FY | 2022 |
収益: | $257.31M |
総利益: | $111.17M (43.20 %) |
EPS: | $-1.780 |
FY | 2021 |
収益: | $253.74M |
総利益: | $105.79M (41.69 %) |
EPS: | $-0.110 |
FY | 2020 |
収益: | $197.32M |
総利益: | $81.29M (41.20 %) |
EPS: | $-1.660 |
Financial Reports:
No articles found.
Heska Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.100 | 2012-03-28 |
Last Dividend | $0.100 | 2012-09-26 |
Next Dividend | $0 | N/A |
Payout Date | 2012-10-10 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | $0.300 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.62 | -- |
Div. Sustainability Score | 3.02 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0.315 | -- |
Year | Amount | Yield |
---|---|---|
2012 | $0.300 | 4.08% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.106 | 1.500 | -2.12 | -3.18 | [0 - 0.5] |
returnOnAssetsTTM | -0.0230 | 1.200 | -0.766 | -0.920 | [0 - 0.3] |
returnOnEquityTTM | -0.0324 | 1.500 | -1.472 | -2.21 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 5.64 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 3.82 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 2.96 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.185 | -1.500 | 6.92 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -8.49 | 1.000 | -4.25 | -4.25 | [3 - 30] |
operatingCashFlowPerShareTTM | -1.186 | 2.00 | -0.395 | -0.791 | [0 - 30] |
freeCashFlowPerShareTTM | -1.417 | 2.00 | -0.708 | -1.417 | [0 - 20] |
debtEquityRatioTTM | 0.262 | -1.500 | 8.95 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.429 | 1.000 | 6.18 | 6.18 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0920 | 1.000 | -3.84 | -3.84 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.113 | 1.000 | -1.737 | -1.737 | [0.2 - 2] |
assetTurnoverTTM | 0.217 | 0.800 | -1.886 | -1.508 | [0.5 - 2] |
Total Score | 3.02 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -91.49 | 1.000 | -9.34 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0324 | 2.50 | -0.946 | -2.21 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -1.417 | 2.00 | -0.472 | -1.417 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -1.186 | 2.00 | -0.395 | -0.791 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.0572 | 1.500 | -3.71 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.0957 | 1.000 | -4.89 | 0 | [0.1 - 0.5] |
Total Score | -2.39 |
Heska Corp
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was founded in 1988 and is based in Loveland, Colorado.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。